Tavist-D Interactions
There are 457 drugs known to interact with Tavist-D (clemastine / phenylpropanolamine), along with 9 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 56 are major, 396 are moderate, and 5 are minor.
- View all 457 medications that may interact with Tavist-D
- View Tavist-D alcohol/food interactions (2)
- View Tavist-D disease interactions (9)
Most frequently checked interactions
View interaction reports for Tavist-D (clemastine / phenylpropanolamine) and the medicines listed below.
- acetaminophen
- Advil (ibuprofen)
- Allegra Allergy (fexofenadine)
- amoxicillin
- Aspir 81 (aspirin)
- atorvastatin
- Benadryl Allergy (diphenhydramine)
- candesartan
- cefuroxime
- cephalexin
- cetirizine
- chlorpheniramine
- clindamycin topical
- clopidogrel
- dapagliflozin
- dasatinib
- desloratadine
- dextromethorphan
- Drixoral Cold and Allergy (dexbrompheniramine / pseudoephedrine)
- ezetimibe
- fexofenadine
- lisinopril
- loratadine
- losartan
- metoprolol
- naproxen
- nitroglycerin
- pramoxine topical
- pseudoephedrine
- ramipril
Tavist-D alcohol/food interactions
There are 2 alcohol/food interactions with Tavist-D (clemastine / phenylpropanolamine).
Tavist-D disease interactions
There are 9 disease interactions with Tavist-D (clemastine / phenylpropanolamine) which include:
- cardiovascular disease
- anticholinergic effects
- asthma/COPD
- cardiovascular
- renal/liver disease
- psychosis
- BPH
- diabetes
- glaucoma
More about Tavist-D (clemastine / phenylpropanolamine)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: upper respiratory combinations
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.